Duhn Therapeutics

Private

DijonHealthcare & Life Scienceshttps://www.duhn-therapeutics.com/

Last Round

Strategic

Oct 23, 2024

Company Overview

Duhn Therapeutics is a biotechnology company that develops lipid-based cancer immunotherapies to treat solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cancer immunotherapybiotechnologysmall molecule drugsolid tumor treatmentlipid-based therapydrug discoveryclinical-stage biotechimmunosuppressionTLR antagonistTLR agonistbiotech licensingoncology pipelinedrug developmentbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Duhn Therapeutics Comparables

Compare Duhn Therapeutics with similar companies based on industry and business-model similarity.

Duhn Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
BiPER Therapeutics	76%
Stimunity	72%
Boehringer Ingelheim	70%

View all Comparables

Duhn Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Strategic	Oct 23, 2024

View all Funding Rounds

Duhn Therapeutics Investors

Notable investors and investment history

Duhn Therapeutics investors
Investor	Rounds
Landmark BioVentures AG	Strategic

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 14, 2026
Monthly visitors grew 190% MoM, reaching 1.3K.
Mar 5, 2026
Monthly visitors grew 121% MoM, reaching 1.8K.

View all signals

Duhn Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Duhn Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Duhn Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDijon

Employee Range2

Year Founded2024

Last FundingOct 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.